Basalt-3 (#531)
Laufzeit: 01.01.2013 - 31.12.2019
imported
Kurzfassung
A phase Ib/II study of docetaxel with or without buparlisib as second line therapy for patients with advanced or metastatic squamous non-small cell lung cancer
